Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
BMJ Open|March 3, 2021
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trialVisalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 12, 2021
Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancersDhanusha Sabanathan, Douglas H Campbell, Vicki M Velonas, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2018
ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate CancerJ Athene Lane, Vanessa Er, Kerry N L Avery, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
British Journal of Cancer|December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
The New England Journal of Medicine|September 15, 2016
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
European Urology|October 11, 2016
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT TrialThomas J Johnston, Greg L Shaw, Alastair D Lamb, et al.
European Urology|November 28, 2019
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment ReceivedDavid E Neal, Chris Metcalfe, Jenny L Donovan, et al.
BJU International|April 4, 2022
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)Janet Athene Lane, Jenny L Donovan, Grace J Young, et al.
Pageof 8